NDC codes

FDA NDC Directory
Product NDC (as listed)82228-712Labeler and product segments. Claims need a package NDC.
Product NDC at billing width82228-0712Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
82228-712-28822280712284 DOSE PACK in 1 CARTON (82228-712-28) / 1 BLISTER PACK in 1 DOSE PACK / 28 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Nov 22, 2024
82228-712-30822280712301 BOTTLE in 1 CARTON (82228-712-30) / 120 TABLET, FILM COATED in 1 BOTTLEMarketed from Jun 18, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Attruby
Generic name (nonproprietary)
acoramidis hydrochloride
Active ingredients
Acoramidis hydrochloride — 356 mg/1
Dosage form
Tablet, Film coated
Route
Oral
Labeler
BridgeBio Pharma, Inc.NDC labeler code 82228
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 216540
Marketing start
Listing expires
Other FDA classes
Cytochrome P450 2C9 Inhibitors (Mechanism)Transthyretin Stabilizers (Mechanism)
Identifiers
Product ID 82228-712_c0fcfa4c-0b57-4260-839e-51171b7f1baaSPL ID c0fcfa4c-0b57-4260-839e-51171b7f1baaSPL set ID 913552ef-875d-4cb7-bf05-a7d20a394c38RxCUI 2698318, 2698324UNII VY9C88C2NVUPC 0382228712287, 0382228712300
Pharmacologic class
Transthyretin Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482228071228 followed by a unit qualifier and the quantity

Package 82228-0712-28. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

ATTRUBY is indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death and cardiovascular-related hospitalization. ATTRUBY is a transthyretin stabilizer indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death and cardiovascular-related hospitalization. ( 1 , 2.1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 82228-712

What is NDC 82228-712?
82228-712 is the product NDC for Attruby (acoramidis hydrochloride), Acoramidis hydrochloride 356 mg/1 tablet, film coated, listed with the FDA by BridgeBio Pharma, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Attruby (Acoramidis hydrochloride).
What is the active ingredient?
Acoramidis hydrochloride.
Who is the labeler?
BridgeBio Pharma, Inc., NDC labeler code 82228. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Attruby?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in